The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes
Open accessAbstract
The clinical associations of glycine receptor antibodies have not yet been described fully. We identified prospectively 52 antibody-positive patients and collated their clinical features, investigations and immunotherapy responses. Serum glycine receptor antibody endpoint titres ranged from 1:20 to 1:60 000. In 11 paired samples, serum levels were higher than (n = 10) or equal to (n = 1) cerebrospinal fluid levels; there was intrathecal synthesis of glycine receptor antibodies in each of the six pairs available for detailed study. Four patients also had high glutamic acid decarboxylase antibodies (>1000 U/ml), and one had high voltage-gated potassium channel-complex antibody (2442 pM). Seven patients with very low titres (<1:50) and unknown or alternative diagnoses were excluded from further study. Three of the remaining 45 patients had newly-identified thymomas and one had a lymphoma. Thirty-three patients were classified as progressive encephalomyelitis with rigidity and myoclonus, and two as stiff person syndrome; five had a limbic encephalitis or epileptic encephalopathy, two had brainstem features mainly, two had demyelinating optic neuropathies and one had an unclear diagnosis. Four patients (9%) died during the acute disease, but most showed marked improvement with immunotherapies. At most recent follow-up, (2-7 years, median 3 years, since first antibody detection), the median modified Rankin scale scores (excluding the four deaths) decreased from 5 at maximal severity to 1 (P < 0.0001), but relapses have occurred in five patients and a proportion are on reducing steroids or other maintenance immunotherapies as well as symptomatic treatments. The glycine receptor antibodies activated complement on glycine receptor-transfected human embryonic kidney cells at room temperature, and caused internalization and lysosomal degradation of the glycine receptors at 37°C. Immunoglobulin G antibodies bound to rodent spinal cord and brainstem co-localizing with monoclonal antibodies to glycine receptor-α1. Ten glycine receptor antibody positive samples were also identified in a retrospective cohort of 56 patients with stiff person syndrome and related syndromes. Glycine receptor antibodies are strongly associated with spinal and brainstem disorders, and the majority of patients have progressive encephalomyelitis with rigidity and myoclonus. The antibodies demonstrate in vitro evidence of pathogenicity and the patients respond well to immunotherapies, contrasting with earlier studies of this syndrome, which indicated a poor prognosis. The presence of glycine receptor antibodies should help to identify a disease that responds to immunotherapies, but these treatments may need to be sustained, relapses can occur and maintenance immunosuppression may be required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis
Hughes, E. G., Peng, X., Gleichman, A. J., Lai, M., Zhou, L., Tsou, R., Parsons, T. D., Lynch, D. R., Dalmau, J., & Balice-Gordon, R. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0167-10.2010 · Cited by 1,143
Irani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035
Self-citationMolecular Structure and Function of the Glycine Receptor Chloride Channel
Lynch, J. W. (2004) · Physiological Reviews · doi:10.1152/physrev.00042.2003 · Cited by 778
Saiz, A., Blanco, Y., Sabater, L., González, F., Bataller, L., Casamitjana, R., Ramió-Torrentà, L., & Graus, F. (2008) · Brain · doi:10.1093/brain/awn183 · Cited by 623
GlyR α3: An Essential Target for Spinal PGE 2 -Mediated Inflammatory Pain Sensitization
Harvey, R. J., Depner, U. B., Wässle, H., Ahmadi, S., Heindl, C., Reinold, H., Smart, T. G., Harvey, K., Schütz, B., Abo-Salem, O. M., et al. (2004) · Science · doi:10.1126/science.1094925 · Cited by 598
Autoantibodies associated with diseases of the CNS: new developments and future challenges
Vincent, A., Bien, C. G., Irani, S. R., & Waters, P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70096-5 · Cited by 542
Self-citationThe glycinergic inhibitory synapse
Legendre, P. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000899 · Cited by 541
IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†
Leite, M. I., Jacob, S., Viegas, S., Cossins, J., Clover, L., Morgan, B. P., Beeson, D., Willcox, N., & Vincent, A. (2008) · Brain · doi:10.1093/brain/awn092 · Cited by 527
Self-citationAntibodies to glutamic acid decarboxylase define a form of limbic encephalitis
Malter, M. P., Helmstaedter, C., Urbach, H., Vincent, A., & Bien, C. G. (2010) · Annals of Neurology · doi:10.1002/ana.21917 · Cited by 514
Self-citationNeuronal autoantigens—pathogenesis, associated disorders and antibody testing
Lancaster, E., & Dalmau, J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.99 · Cited by 512
Myasthenic Antibodies Cross-Link Acetylcholine Receptors to Accelerate Degradation
Drachman, D. B., Angus, C. W., Adams, R. N., Michelson, J. D., & Hoffman, G. J. (1978) · New England Journal of Medicine · doi:10.1056/nejm197805182982004 · Cited by 437
High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome
Dalakas, M. C., Fujii, M., Li, M., Lutfi, B., Kyhos, J., & McElroy, B. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa01167 · Cited by 434
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
Jarius, S., & Wildemann, B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.72 · Cited by 423
Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders
Dale, R. C., Merheb, V., Pillai, S., Wang, D., Cantrill, L., Murphy, T. K., Ben-Pazi, H., Varadkar, S., Aumann, T. D., Horne, M. K., et al. (2012) · Brain · doi:10.1093/brain/aws256 · Cited by 388
Native glycine receptor subtypes and their physiological roles
Lynch, J. W. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.034 · Cited by 377
PROGRESSIVE ENCEPHALOMYELITIS, RIGIDITY, AND MYOCLONUS: A NOVEL GLYCINE RECEPTOR ANTIBODY
Hutchinson, M., Waters, P., McHugh, J., Gorman, G., O’Riordan, S., Connolly, S., Hager, H., Yu, P., Becker, C. M., & Vincent, A. (2008) · Neurology · doi:10.1212/01.wnl.0000327606.50322.f0 · Cited by 362
Self-citationTüzün, E., Zhou, L., Baehring, J. M., Bannykh, S., Rosenfeld, M. R., & Dalmau, J. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0582-4 · Cited by 360
Stiff-Man Syndrome and Variants: Clinical Course, Treatments, and Outcomes
McKeon, A. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.991 · Cited by 300
Aquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse Myelitis
Waters, P., Jarius, S., Littleton, E., Leite, M. I., Jacob, S., Gray, B., Geraldes, R., Vale, T., Jacob, A., Palace, J., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.7.913 · Cited by 294
Self-citationZuliani, L., Graus, F., Giometto, B., Bien, C., & Vincent, A. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301237 · Cited by 293
Self-citationHacohen, Y., Wright, S., Waters, P., Agrawal, S., Carr, L., Cross, H., De Sousa, C., DeVile, C., Fallon, P., Gupta, R., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303807 · Cited by 269
Self-citationGlycine Receptor Autoimmune Spectrum With Stiff-Man Syndrome Phenotype
McKeon, A., Martinez-Hernandez, E., Lancaster, E., Matsumoto, J. Y., Harvey, R. J., McEvoy, K. M., Pittock, S. J., Lennon, V. A., & Dalmau, J. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.574 · Cited by 211
Distribution of glycine-immunoreactive cell bodies and fibers in the rat brain
Rampon, C., Luppi, P. H., Fort, P., Peyron, C., & Jouvet, M. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00278-3 · Cited by 207
Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition
Geis, C., Weishaupt, A., Hallermann, S., Grünewald, B., Wessig, C., Wultsch, T., Reif, A., Byts, N., Beck, M., Jablonka, S., et al. (2010) · Brain · doi:10.1093/brain/awq253 · Cited by 198
Self-citationInhibitory Glycine Receptors: An Update
Dutertre, S., Becker, C.-M., & Betz, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.408229 · Cited by 193
Koneczny, I., Cossins, J., Waters, P., Beeson, D., & Vincent, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080695 · Cited by 184
Self-citationAraki, T., Yamano, M., Murakami, T., Wanaka, A., Betz, H., & Tohyama, M. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90263-1 · Cited by 155
Antiglycine-receptor encephalomyelitis with rigidity
Mas, N., Saiz, A., Leite, M. I., Waters, P. J., Baron, M., Castano, D., Sabater, L., Vincent, A. C., & Graus, F. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.229104 · Cited by 154
Self-citationGlycine and glycine receptor signaling in hippocampal neurons: Diversity, function and regulation
Xu, T., & Gong, N. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.008 · Cited by 140
Glycinergic transmission in the mammalian retina
Wässle, H. (2009) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.006.2009 · Cited by 126
Rigidity and spasms from autoimmune encephalomyelopathies: Stiff‐person syndrome
Espay, A. J., & Chen, R. E. (2006) · Muscle & Nerve · doi:10.1002/mus.20653 · Cited by 111
Progressive encephalomyelitis with rigidity and myoclonus: Glycine and NMDA receptor antibodies
Turner, M. R., Irani, S. R., Leite, M. I., Nithi, K. A., Vincent, A. C., & Ansorge, O. (2011) · Neurology · doi:10.1212/wnl.0b013e318227b176 · Cited by 106
Self-citationHansen, N., Grünewald, B., Weishaupt, A., Colaço, M. N., Toyka, K. V., Sommer, C., & Geis, C. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.10.013 · Cited by 98
Glycine-Gated Chloride Channels Depress Synaptic Transmission in Rat Hippocampus
Song, W., Chattipakorn, S. C., & McMahon, L. L. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00386.2005 · Cited by 83
Glycinergic synaptic currents in Golgi cells of the rat cerebellum.
Dieudonné, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1441 · Cited by 79
Progressive Encephalomyelitis With Rigidity and Myoclonus
Damásio, J., Leite, M. I., Coutinho, E., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1872 · Cited by 72
Self-citationA critical update on the immunopathogenesis of Stiff Person Syndrome
Alexopoulos, H., & Dalakas, M. C. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02340.x · Cited by 69
Meinck, H. ‐. (2006) · Neurophysiologie Clinique · doi:10.1016/j.neucli.2006.12.007 · Cited by 59
Self-citationIizuka, T., Leite, M. I., Lang, B., Waters, P. J., 浦野義章, Miyakawa, S., Hamada, J., Sakai, F., Mochizuki, H., & Vincent, A. C. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6377-2 · Cited by 57
Self-citationWaldvogel, H. J., Baer, K., Eady, E. K., Allen, K. L., Gilbert, R. T., Möhler, H., Rees, M. I., Nicholson, L. F. B., & Faull, R. L. M. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.22212 · Cited by 57
Geis, C., Grünewald, B., Weishaupt, A., Wultsch, T., Toyka, K. V., Reif, A., & Sommer, C. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0773-3 · Cited by 50
Glycine-like immunoreactive input to sympathetic preganglionic neurons
Cabot, J. B., Alessi, V., & Bushnell, A. F. (1992) · Brain Research · doi:10.1016/0006-8993(92)90504-3 · Cited by 39
Piotrowicz, A., Thümen, A., Leite, M. I., Vincent, A. C., & Moser, A. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6078-x · Cited by 39
Self-citationChan, D. W. S., Thomas, T. G. S., Lim, M. J., Ling, S. R., Woodhall, M. R., & Vincent, A. C. (2016) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2016.08.013 · Cited by 20
Self-citation
Cited by
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Self-citationAntibody-Mediated Encephalitis
Dalmau, J., & Graus, F. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1708712 · Cited by 1,329
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
Graus, F., Vogrig, A., Muñiz-Castrillo, S., Antoine, J.-C. G., Desestret, V., Dubey, D., Giometto, B., Irani, S. R., Joubert, B., Leypoldt, F., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001014 · Cited by 759
Dalmau, J., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 628
The Diagnosis and Treatment of Autoimmune Encephalitis
Lancaster, E. (2016) · Journal of Clinical Neurology · doi:10.3988/jcn.2016.12.1.1 · Cited by 437
Metadata
- Authors
- Carvajal-González, A., Leite, M. I., Waters, P., Woodhall, M., Coutinho, E., Balint, B., Lang, B., Pettingill, P., Carr, A., Sheerin, U.-M., Press, R., Lunn, M. P., Lim, M., Maddison, P., Meinck, H.-M., Vandenberghe, W., & Vincent, A.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-06-20
- Volume
- 137
- Issue
- 8
- Pages
- 2178-2192
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2103644035
- Cited by
- 532
- References
- 45
- FWCI
- 25.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.